Research interests include PARP inhibition in cancer therapy, Ovarian cancer diagnosis and treatment, BRCA gene mutations in cancer, and Cancer Treatment and Pharmacology.
Atezolizumab Combined With Bevacizumab and Platinum-Based Therapy for Platinum-Sensitive Ovarian Cancer: Placebo-Controlled Randomized Phase III ATALANTE/ENGOT-ov29 Trial
Journal of Clinical Oncology2023cited by 100position: middledoi